Holocene Advisors’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240M Buy
2,468,644
+560,696
+29% +$56.6M 0.58% 39
2025
Q4
$152M Sell
1,907,948
-1,529,335
-44% -$100M 0.32% 87
2025
Q3
$161M Sell
3,437,283
-195,669
-5% -$7.66M 0.37% 66
2025
Q2
$134M Sell
3,632,952
-58,792
-2% -$2.26M 0.33% 85
2025
Q1
$131M Buy
3,691,744
+695,034
+23% +$28.2M 0.39% 79
2024
Q4
$131M Buy
2,996,710
+847,149
+39% +$42.8M 0.43% 64
2024
Q3
$97.5M Sell
2,149,561
-53,913
-2% -$2.35M 0.39% 86
2024
Q2
$85.5M Sell
2,203,474
-218,937
-9% -$8.18M 0.36% 89
2024
Q1
$78.1M Sell
2,422,411
-459,744
-16% -$13.6M 0.29% 110
2023
Q4
$82.7M Buy
2,882,155
+691,433
+32% +$16.6M 0.32% 106
2023
Q3
$60.6M Buy
2,190,722
+12,662
+0.6% +$376K 0.27% 119
2023
Q2
$58.3M Buy
2,178,060
+73,242
+3% +$1.8M 0.25% 122
2023
Q1
$45.6M Buy
+2,104,818
New +$51.8M 0.23% 137

Other funds holding RVMD